Printed From BioPortfolio.com
Stem cell transplant improves overall, event-free survival in scleroderma
17:00 EST 3 Jan 2018 | Healio
Myeloablative autologous stem cell transplantation improved long-term clinical outcomes, including overall survival and event-free survival, among patients with diffuse cutaneous systemic sclerosis, according to findings published in the New England Journal of Medicine.
“Scleroderma with internal organ involvement is a devastating autoimmune disorder with considerable morbidity and high mortality which have not changed in 40 years of reporting,” Keith M. Sullivan, MD, of Duke University Medical Center, told Healio Rheumatology. “Effective new therapies are needed.”
Original Article: Stem cell transplant improves overall, event-free survival in scleroderma
